Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis–associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension

Rationale: Patients with systemic sclerosis–associated pulmonary arterial hypertension (SSc-PAH) continue to have an unacceptably high mortality rate despite the progress achieved with pulmonary arterial vasodilator therapies. Objectives: We sought to determine whether SSc-PAH is a clinically distin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Am Thorac Soc
Egile Nagusiak: Argula, Rahul G., Karwa, Abhijit, Lauer, Abigail, Gregg, David, Silver, Richard M., Feghali-Bostwick, Carol, Schanpp, Lynn M., Egbert, Kim, Usher, Bruce W., Ramakrishnan, Viswanathan, Hassoun, Paul M., Strange, Charlie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Thoracic Society 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802595/
https://ncbi.nlm.nih.gov/pubmed/28282243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201608-655OC
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak